Oncimmune Holdings PLC (LSE:ONC)
£ 0.147 -0.001 (-0.67%) Market Cap: 16.43 Mil Enterprise Value: 20.78 Mil PE Ratio: 1.29 PB Ratio: 0 GF Score: 41/100

Full Year 2020 Oncimmune Holdings PLC Earnings Call Transcript

Oct 30, 2020 / NTS GMT
Release Date Price: £1.61 (-9.58%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Oncimmune Holdings PLC full year results investor presentation. (Operator Instructions) The company may not be in a position to answer every question received during the meeting itself. However, the company review all questions submitted today and publish responses where it is appropriate to do so. These will be available via Investor Meet company dashboard.

Before we begin, we would like to submit to the following poll. I'd like to remind you that this presentation is being recorded. And I'd now like to hand over to Adam Hill, CEO and Matthew Hall, CFO. Good afternoon.

Adam Hill
Oncimmune Holdings PLC - CEO

Good afternoon and thanks very much, Paul. Ladies and gentlemen, thank you for joining us this afternoon. I'm joined by my colleague, Matthew Hall, the Chief Finance Officer at Oncimmune, and myself, I'm the Chief Executive at Oncimmune.

So we're presenting today the financial year 2020 full results and progress update. Many of you who have heard me speak before will recognize that our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot